ABCL

AbCellera Biologics, Inc

Halal Rating :
Uncomfortable
See Details
Last Price $3.05 Last updated:
Market Cap $1.19b
7D Change -2.9%
1 Year Change -2.9%

Company Overview

Industries
Exchange NASDAQ
Next Earnings Date Feb. 20, 2024

AbCellera Biologics Inc. develops an antibody discovery platform. The company is headquartered in Vancouver, Canada.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $9.95m $90.41m $10.4m - 104.49% 0.00%
Dec. 31, 2023 $9.18m $118.57m $10.97m $16.73m 119.50% 14.11%
Sept. 30, 2023 $6.6m $85.06m $10.74m - 162.75% 0.00%

Company Impact

Help us evaluate AbCellera Biologics, Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates